Journal
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Volume 36, Issue 7, Pages 923-933Publisher
WILEY
DOI: 10.1002/hed.23340
Keywords
transoral robotic surgery; chemoradiotherapy; health states; utilities; preferences; oropharyngeal cancer
Categories
Ask authors/readers for more resources
Background. Treatment of oropharyngeal cancer with transoral robotic surgery (TORS) or definitive (chemo)radiotherapy impacts quality of life. Utility scores are needed for quality of life and economic comparisons. Methods. Fifty healthy subjects and 9 experts reviewed scenarios describing treatment (TORS alone or with adjuvant radiotherapy or chemoradiotherapy [CRT], definitive radiotherapy, and CRT), complications, remission, and recurrences. Utilities were assessed using visual analog scale (VAS) and standard gamble (SG) techniques. Treatments were compared using paired comparisons and demographic variability was assessed. Results. TORS had higher SG utilities than radiotherapy (p = .001) and CRT (p < .001) and was preferred in paired comparisons (p < .001 for both) for healthy subjects. Utilities did not vary by demographic group and correlated between experts and subjects (VAS r = 0.95; p < .001; SG r = 0.97; p < .001). Conclusion. TORS has higher utility scores than CRT. Utilities can be used for cost-utility analyses. (C) 2014 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available